Preview

Siberian journal of oncology

Advanced search

The level of sialic acids and imidazole compounds in the saliva of patients with lung cancer of different histological types

https://doi.org/10.21294/1814-4861-2018-17-6-84-91

Abstract

In recent years, the possibility of using known and new tumor markers in primary and differential diagnosis of lung cancer has been actively studied.

The purpose of the study was to study the level of sialic acids, the total content of imidazole compounds and seromucoids in the saliva of patients with lung cancer, depending on the histological type of tumor.

Material and Methods. Total of 478 people took part in in the case-control study. They were divided into 3 groups: the main group (lung cancer, n=218), the comparison group (nonmalignant lung pathologies, n=60) and the control group (conditionally healthy, n=200).

Results. Patients with non-malignant lung pathologies exhibited increased levels of imidazole compounds and seromucoids and decreased levels of sialic acids. A statistically significant decrease in the level of sialic acids was observed in patients with non-small cell lung cancer. The concentration of imidazole compounds was significantly higher in all study groups, except for carcinoid tumors. The nature of the changes in the studied parameters were ambiguous and depended on both the histological type of the tumor and the stage of the disease, including the presence / absence of distant and regional metastasis.

About the Authors

L. V. Belskaya
ChemService; Omsk State Medical University
Russian Federation

Lyudmila V. Belskaya - PhD, Associate Professor, Department of Chemical Technology and Biotechnology.

4/2, Lugovaya Street, Skolkovo Innovation Center-143026; 11, Prospect Mira, 644050-Omsk



V. K. Kosenok
ChemService; Omsk State Medical University
Russian Federation

Viktor K. Kosenok - MD, Professor, Member of the Russian Academy of Sciences, Head of Oncology Department with the Course of Radiation Therapy

4/2, Lugovaya Street, Skolkovo Innovation Center-143026; 12, Lenin Street, 644099-Omsk



References

1. Mukeria A.F., Zaridze D.G. Lung cancer epidemiology and prevention. Journal of N.N. Blokhin Russian Cancer. 2010; 21 (3): 3-13. (in Russian).

2. Nidyulin У.А., ErdnievaB.V. About epidemiology of carcinoma of lungs. Bashkortostan Medical Journal. 2009; 4 (1): 66-71. (in Russian).

3. Tran T.T., Nguyen T.M.P., Nguyen B.N., Phan VC. Changes of Serum Glycoproteins in Lung Cancer Patients. J Proteom Bioinformat. 2008;1:11-16.

4. Shamberger R.J. Serum sialic acid in normal and cancer patients. J Clin Chem Clin Biochem. 1984 Oct; 22 (10): 647-51.

5. Bowrey P.F., King J., Magarey C., SchwartzP., Marr P, Bolton E., Morris D.L. Histamine, mast cells and tumor cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? Br J Cancer. 2000; 82 (1): 167-70. doi: 10.1054/bjoc.1999.0895.

6. WongD.T. Salivary Diagnostics. Wiley-Blackwell, 2008. 320.

7. Malathi N., Mythili S., Vasanthi H.R. Salivary Diagnostics: A Brief Review. ISRN Dent. 2014 Jan 29; 2014: 158786. doi: 10.1155/2014/158786.

8. Miller C.S., Foley J.D., BaileyA.L., Campell C.L., Humphries R.L., Christodoulides N., Floriano P.N., Simmons G., Bhagwandin B., Jacobson J.W., Redding S.W., Ebersole J.L., McDevitt J.T. Current developments in salivary diagnostics. Biomark Med. 2010; 4 (1): 171-89.

9. Arunkumar S., Arunkumar J.S., Krishna N.B., Shakunthala G.K. Developments in diagnostic applications of saliva in oral and systemic diseases A comprehensive review. J Sci Innov Res. 2014; 3 (3): 372-87.

10. Nunes L.A., Mussavira S., Bindhu O.S. Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review. Biochem Med (Zagreb). 2015 Jun 5; 25 (2): 177-92. doi: 10.11613/BM.2015.018.

11. MogilnajaG.M., Durleshter VM., Mogilnaja VL., Ignatenko V.V. Mucins in assessment of tumoral biopotential. Kuban Scientific Medical Bulletin. 2014; 146 (4): 88-92. (in Russian).

12. eran-sky V.V., Alyekhin Ye.K., Petrova I.V,Alyekhin VYe. The role of histamine and antihistamine drugs in oncogenesis. 2010; 5 (4): 151-56. (in Russian).

13. FlemingM.V, Klimov V.V, Cherdyntseva N.V On the mutual influence of allergic reactions and malignant processes. Siberian Journal of Oncology. 2005; 1: 96-101. (in Russian).

14. KeskinegeA., Elgun S., YitmazE. Possible implications of arginase and diamine oxidase in prostatic carcinoma. Cancer Detect. Prev. 2001; 25 (1): 76-9.

15. ManinaI.V, Peretolchi-na N.M., Saprikina N.S., Kozlov A.M., Mikhaylova I.N., Jordanya K.I., Barishnikov A.Y. Prospects of using antagonist histamine 42-receptor (cimetidinum) as adjuvant for melanoma biotherapy treatment. Immunopa-thology, Allergology, Infectology. 2010; 4: 42-51. (in Russian).

16. FaverioF., GuzzettiA., MereghettiA., JemoliR. Hiperhistaminemia nelle neoplasie della mammilla. Chir Ital. 1982; 34 (5): 727-34.

17. Бельская Л.В., Сарф Е.А., Косенок В.К. Биохимия слюны: методы исследования. Омск, 2015. 70. [Belskaya L.V, Sarf EA., Ko-senok V.K. Biochemistry of saliva: research methods. Omsk, 2015. 70. (in Russian)].

18. StoyanovE., UddinM., MankutaD., DubinettS.M., Levi-SchafferF. Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer. 2012 Jan; 75 (1): 38-44. doi: 10.1016/j.lungcan.2011.05.029.

19. Khailihiko VA., Davidov M.I., Novikov A.M., Speransky D.L. Clinical value of sialic acids in lung cancer patients. Journal of N.N. Blokhin Russian Cancer. 1991; 2 (1): 25-27. (in Russian).

20. Isitmangil T., Isitmangil G., Budak Y., Aydilek R., Celenk M.K. Comparison of serum and bronchoalveolar lavage fluid sialic acid level between malignant and benign lung diseases. Pulm Med. 2001; 1: 1-5.

21. Chen S., Fukuda M. Cell type-specific roles of carbohydrates in tumor metastasis. Methods in enzymology. 2066; 416: 371-380.

22. ParkashA., SinglaP, SethM., AgarwalH.K. Study of serum total sialic acid level and its correlation with atherogenic index in cases of acute myocardial infarction. Int J Pharma Bio Science. 2011; 2: 8-14.

23. Vedralova E., Borovansky J. Evolution of serum sialic acid fraction as markers for malignant melanoma. Ann Clin Labor Sci. 2003; 33: 156-59.

24. Bragava N.V Glycoproteins and glycolipids. Med Biochem. 2002;102: 153-71.

25. MaslakA.S., Kostyuk O. V, Mashejko I. V, BrazalukA.Z. The content of a-1 acid glycoprotein and sialic acids in biological fluids in patients with chronic myeloproliferative disease. Journal of Grodno State Medical University. 2013; 1: 39-41. (in Russian).

26. Matveeva O. V, Kochneva G. V, NetesovS.V., OnikienkoS.B., ChumakovP.M. Mechanisms of oncolysis by paramyxovirus Sendai. Acta Naturae. 2015; 7 (2): 6-16. (in Russian).

27. Kondratyuk R.B., Vasilenko I.V, Gulkov Yu.K. Lectin-histochemical assessment of carbohydrate determinants in tumour cells of main histological types of gastric cancer. Pathology. 2015; 33 (1): 73-9. (in Russian).

28. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., UnoK. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg. 2004; 127 (4): 1087-92.

29. Halliwell B. Free radicals and antioxidants: updating a personal view. Nurture Review. 2012; 70 (5): 257-65.

30. Lapeshin P.V, SavchenkoA.A., Dichno U.A., Moskovskich M.N., Denisov I.N., Kolenchukova O.A. Phenotypic composition of blood lymphocytes and lymph nodes in patients witadenocarcinoma and squamous cell carcinoma of the lung. Siberian Journal of Oncology. 2005; 2: 34-38. (in Russian).

31. Raykhlin N.T., Bukaeva I.A., Smirnova E.A., Ponomareva M.V, Chekini A.K., PavlovskayaA.I., ShabanovMA. Pulmonary carcnoid: proliferative activity, grade and prognosis. Journal of N.N. Blokhin Russian Cancer. 2012; 23 (4): 17-24. (in Russian).


Review

For citations:


Belskaya L.V., Kosenok V.K. The level of sialic acids and imidazole compounds in the saliva of patients with lung cancer of different histological types. Siberian journal of oncology. 2018;17(6):84-91. (In Russ.) https://doi.org/10.21294/1814-4861-2018-17-6-84-91

Views: 1264


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)